Home / Tobramycin / Czechia
CZ ATC S01AA12 · updated 2 Nov 2026
Tobramycin shortage in Czechia
Is there a Tobramycin shortage in Czechia?
Yes. As of 2 Nov 2026, 1 Tobramycin product is reported short in Czechia. The company estimate for the return is 16 Nov 2026. Main reason: manufacturing problem.
Also short in Canada, Spain, Austria. All countries.
Affected products in Czechia
| Country | Product | Company | Since | Expected back | Reason |
|---|---|---|---|---|---|
| CZ | TOBREX 3MG/G 3MG/G OPH UNG 3,5G anticipated | Novartis s.r.o., Praha | 4 Nov 2026 | 16 Nov 2026 | Manufacturing problem Výrobní důvody |
Source
SÚKL (State Institute for Drug Control), market reports. Official list. Products whose latest market report is a supply interruption; one row per SÚKL code.